CLNN compared with NGEN: revenue, margins and what each company keeps, and the suppliers and customers both name

CLNNClene Inc.

Mkt capRevenueRevenue

NGENNervgen Pharma Corp.

Mkt capRevenueRevenue

Compare

CLNNClene Inc.

NGENNervgen Pharma Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CLNN: latest quarter is a loss; flow not drawable. NGEN: latest quarter not drawable.Method ›

Price

rebased to 0%

CLNN, solidNGEN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CLNN 12

—George Washington Universityunlistedsupplier

—Johns Hopkins Universityunlistedsupplier

—Northwestern Universityunlistedsupplier

—University of Cambridgeunlistedsupplier

8 more · CLNN chain ›

Shared 0

No disclosed counterparties: NGEN.

Only NGEN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CLNNClene Inc.

3.89▼−0.30%· post 3.89

Mkt cap$49.2MRevenue$90,000Q2 FY26Revenue$342,000FY24

NGENNervgen Pharma Corp.

1.37▼−4.86%· post 1.48

ClosedOct 30 '26

Mkt cap$99.1MRevenue—Revenue—

Compare

ClosedOct 30 '26

CLNNClene Inc.

NGENNervgen Pharma Corp.

3.89▼−0.30%post 3.89

Price

1.37▼−4.86%post 1.48

$49.2M

Mkt cap

$99.1M

Q2 FY26$90,000

Revenue

—

FY24$342,000

Revenue

—

CLNN3.89▼−0.30%vsNGEN1.37▼−4.86%ClosedOct 30 '26